| Literature DB >> 31628390 |
Matheus F Vane1, Maria J C Carmona2, Sergio M Pereira2,3, Karl B Kern4, Sérgio Timerman5, Guilherme Perez2, Luiz Antonio Vane6, Denise Aya Otsuki2, José O C Auler2.
Abstract
Data on predictors of intraoperative cardiac arrest (ICA) outcomes are scarce in the literature. This study analysed predictors of poor outcome and their prognostic value after an ICA. Clinical and laboratory data before and 24 hours (h) after ICA were analysed as predictors for no return of spontaneous circulation (ROSC) and 24 h and 1-year mortality. Receiver operating characteristic curves for each predictor and sensitivity, specificity, positive and negative likelihood ratios, and post-test probability were calculated. A total of 167,574 anaesthetic procedures were performed, including 158 cases of ICAs. Based on the predictors for no ROSC, a threshold of 13 minutes of ICA yielded the highest area under curve (AUC) (0.867[0.80-0.93]), with a sensitivity and specificity of 78.4% [69.6-86.3%] and 89.3% [80.4-96.4%], respectively. For the 1-year mortality, the GCS without the verbal component 24 h after an ICA had the highest AUC (0.616 [0.792-0.956]), with a sensitivity of 79.3% [65.5-93.1%] and specificity of 86.1 [74.4-95.4]. ICA duration and GCS 24 h after the event had the best prognostic value for no ROSC and 1-year mortality. For 24 h mortality, no predictors had prognostic value.Entities:
Mesh:
Year: 2019 PMID: 31628390 PMCID: PMC6802384 DOI: 10.1038/s41598-019-51557-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Acquired parameters.
| Patient and Surgery | OR admission* | Pre-CA intraoperative** | Intraoperative CA | Immediately after ROSC&* | 24h after ROSC&** | ||
|---|---|---|---|---|---|---|---|
|
| Gender (Male/Female) | Presence of hypotension (Yes or No) | Vasoactive drug usage (Yes or No) | Cause of CA | Glasgow Coma Scale (≥ 14 or ≥ 10T or <14 or 10T) | ||
Age (<50 or ≥ 50 years) | Consciousness level (Sedated or Awaked) | Presence of arrhythmias (Yes or No) | Defibrillation (Yes or No) | ||||
ASA-PS (I, II, III, IV, or V) | Respiratory monitoring changes (Yes or No) | Initial Rhythm (Shockable, pulseless or asystole) | |||||
Event Shift (Daytime or Nightime) | Cardiovascular monitoring changes (Yes or No) | CA duration (minutes) | |||||
Type of Surgery (Elective, Trauma or Non-Trauma) | Number of epinephrine doses | ||||||
|
| PT/INR (<1.2) | Arterial pH (7.35–7.45) | Arterial pH (7.35–7.45) | Arterial pH (7.35–7.45) | PT/INR (<1.2) | ||
aTTP/R (<1.2) | Arterial Bicarbonate (22–26 mEq/L) | Arterial Bicarbonate (22–26 mEq/L) | Arterial Bicarbonate (22–26 mEq/L) | aTTP/R (<1.2) | |||
Platelet count (140–450,000 platelets/mm³) | Arterial Base Excess (−3 - +3) | Arterial Base Excess (−3 - +3) | Arterial Base Excess (−3 - +3) | Platelet count (140–450,000 platelets/mm³) | |||
Serum creatinine (<1.2 mg/dL) | Sodium levels (135–145 mEq/L) | Sodium levels (135–145 mEq/L) | Sodium levels (135–145 mEq/L) | Serum creatinine (<1.2) | |||
Serum Urea (10–50 mg/dL)) | Potassium levels (3.5–5 mEq/L) | Potassium levels (3.5–5 mEq/L) | Potassium levels (3.5–5 mEq/L) | Serum Urea (10–50) | |||
Chloride levels (98–107 mEq/L) | Chloride levels (98–107 mEq/L) | Chloride levels (98–107 mEq/L) | |||||
Ionic calcium levels (4.4–5.4 mEq/L) | Ionic calcium levels (4.4–5.4 mEq/L) | Ionic calcium levels (4.4–5.4 mEq/L) | |||||
Arterial Lactate (<14.4 mg/dL) | Arterial Lactate (<14.4 mg/dL) | Arterial Lactate (<14.4 mg/dL) | |||||
Glucose levels (70–100 mg/dL) | Glucose levels (70–100 mg/dL) | Glucose levels Glucose levels (70–100 mg/dL) | |||||
Hemoglobin (12–16 g/dL) | Hemoglobin (12–16 g/dL) | Hemoglobin (12–16 g/dL) | |||||
Hematocrit (35–47%) | Hematocrit (35–47%) | Hematocrit (35–47%) | |||||
Variable categorization in parenthesis. aTTP/R: normalized ratio of activated partial thromboplastin time; ASA-PS: American Society of Anesthesiologists Physical Statuts Classification; PT/INR: international normalized ratio of prothrombin time; ROSC: Return of spontaneous circulation.
*Tolerance: 24 h for elective cases and 6 h for urgent/emergent cases; **Tolerance: Clinical data: 60 min before CA; Laboratorial data: 120 minutes before CA; & *Tolerance: 60 min & **Tolerance: 6 h.
Hypotension: Systolic Arterial Pressure <90 mmHg or mean arterial pressure <50 mmHg; Arrhythmias: Any new ECG findings or rhythm changes; Respiratory Monitoring Changes: new findings on oximetry, capnography, airway pressure, or tidal volume; Cardiovascular Monitoring Changes: new findings on heart rate or blood pressure.
Figure 1Study flowgram diagram.
Figure 2Plots of Kaplan-Meier product limit estimates of survival after ICA. (A): for patients with intraoperative cardiac arrest; (B): According to the INR/PT variation; (C): according to GCS 24 h after the event. +: Censoring of two cases who were lost to follow-up.
Predictors for mortality.
| Predictors | PRw | PRadj | CI 95% (PRadj) |
|
|---|---|---|---|---|
|
| ||||
|
| 3.36 | 2.42 | 1.52–3.86 |
|
|
| 1.85 | 1.60 | 1.07–2.40 |
|
|
| 1.03 | 1.03 | 1.02–1.04 |
|
|
| ||||
|
| 3.01 | 4.15 | 1.98–8.68 |
|
| 2.16 | 2.37 | 1.23–4.58 |
| |
| 2.71 | 2.43 | 1.24–4.75 |
| |
|
| 1.03 | 1.04 | 1.03–1.06 |
|
|
| ||||
| 3.50 | 2.70 | 1.52–4.79 |
| |
| 1.29 | 1.66 | 1.11–2.47 |
| |
|
| 1.01 | 1.01 | 1.01–1.04 |
|
CA: Cardiac arrest; 95% CI: 95% Confidence interval; PT/INR: international normalized ratio of prothrombin time; PRaj: Adjusted prevalence ratio; PRr: Raw prevalence ratio.
Sensitivity, specificity and area under curve (AUC) for the predictors.
| Sensitivity | Specificity | AUC | Threshold | p-AUC | ||||
|---|---|---|---|---|---|---|---|---|
| % | 95% | % | 95% | 95% | ||||
| No-ROSC | ||||||||
|
| 78.43 | 69.61–86.27 | 89.29 | 80.36–96.43 | 0.8665 | 0.8004–0.9328 | 13.5 | — |
|
| 77.50 | 68.63–85.29 | 67.90 | 55.36–80.36 | 0.7265 | 0.6526–0.8005 | Hypovolemia |
|
|
| 77.50 | 68.63–85.29 | 44.60 | 32.14–57.14 | 0.6104 | 0.5332–0.6878 | Presence |
|
|
| ||||||||
|
| 61.64 | 50.68–72.60 | 56.67 | 40.00–73.30 | 0.6159 | 0.4997–0.7323 | 10 | — |
|
| 73.97 | 64.38–83.56 | 46.67 | 30.00–63.33 | 0.6032 | 0.4993–0.7072 | Hypovolemia | 0.882 |
|
| 68.25 | 57.14–79.37 | 43.48 | 26.09–65.22 | 0.5310 | 0.3824–0.6797 | 136 | 0.374 |
|
| 58.18 | 45.45–70.91 | 28.57 | 9.52–47.62 | 0.5662 | 0.3149–0.5526 | >1.2 | 0.617 |
|
| ||||||||
|
| 79.31 | 65.52–93.10 | 86.05 | 74.42–95.35 | 0.8737 | 0.7918–0.9556 | 9* | — |
|
| 64.38 | 53.42–75.34 | 79.31 | 65.52–93.10 | 0.7503 | 0.6482–0.8525 | 5.5 | 0.066 |
|
| 18.75 | 6.25–34.38 | 1 | 1 | 0.5937 | 0.5251–0.6624 | Negative |
|
*Glasgow Coma Scale with supression of best vocal response. Legend: CA: Cardiac arrest; 95% CI: 95% Confidence interval; OR: operating room; PT/INR: international normalized ratio of prothrombin time; ROSC: return of spontaneous circulation; p-AUC: vs the highest ROC AUC.
Positive and Negative Likelihood ratios (+LHR, -LHR), post-tests probability for the analyzed thresholds.
| LHR+ | 95%CI | Post-test Probability | 95% CI | LHR− | 95% CI | Post-test Probability | 95% CI | |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
|
| 7.32 | 3.41–16 | 93% | 86–97% | 0.24 | 0.17–0.35 | 30% | 24–39% |
|
| 2.41 | 1.62–3.58 | 81% | 75–87% | 0.33 | 0.22–0.50 | 38% | 29–48% |
|
| 1.40 | 1.08–1.81 | 72% | 66–77% | 0.51 | 0.32–0.80 | 48% | 37–59% |
|
| 1.42 | 0.91–2.23 | 78% | 69–84% | 0.68 | 0.44–1.04 | 62% | 52–72% |
|
| 1.39 | 0.97–1.99 | 77% | 70–83% | 0.56 | 0.32–0.96 | 58% | 44–70% |
|
| 1.18 | 0.79–1.76 | 76% | 68–83% | 0.77 | 0.43–1.37 | 68% | 54–79% |
|
| 0.81 | 0.57–1.16 | 68% | 60–75% | 1.46 | 0.7–3.08 | 79% | 65–89% |
|
| ||||||||
|
| 6.82 | 2.93–16 | 82% | 66–92% | 0.23 | 0.11–0.48 | 13% | 7–24% |
|
| 3.11 | 1.5–6.48 | 89% | 79–94% | 0.45 | 0.31–0.64 | 53% | 44–62% |
|
| Inf | 0.49–139 | 100% | 44–100% | 0.81 | 0.69–0.99 | 56% | 52–61% |
*Glasgow Coma Scale with supression of best vocal response. Legend: CA: Cardiac arrest; 95% CI: 95% Confidence interval; OR: operating room; PT/INR: international normalized ratio of prothrombin time; ROSC: return of spontaneous circulation.